rs72646508

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBS1BS2_Supporting

The NM_174936.4(PCSK9):​c.757C>T​(p.Leu253Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000167 in 1,613,232 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L253H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00089 ( 0 hom., cov: 35)
Exomes 𝑓: 0.000092 ( 2 hom. )

Consequence

PCSK9
NM_174936.4 missense

Scores

3
11
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.77

Publications

25 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03293845).
BP6
Variant 1-55052749-C-T is Benign according to our data. Variant chr1-55052749-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 468298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000893 (136/152376) while in subpopulation AFR AF = 0.00322 (134/41600). AF 95% confidence interval is 0.00278. There are 0 homozygotes in GnomAd4. There are 64 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.757C>Tp.Leu253Phe
missense
Exon 5 of 12NP_777596.2
PCSK9
NM_001407240.1
c.880C>Tp.Leu294Phe
missense
Exon 6 of 13NP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.757C>Tp.Leu253Phe
missense
Exon 5 of 12NP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.757C>Tp.Leu253Phe
missense
Exon 5 of 12ENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.1114C>Tp.Leu372Phe
missense
Exon 5 of 12ENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.880C>Tp.Leu294Phe
missense
Exon 6 of 13ENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.000893
AC:
136
AN:
152258
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000193
AC:
48
AN:
248974
AF XY:
0.000141
show subpopulations
Gnomad AFR exome
AF:
0.00298
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000917
AC:
134
AN:
1460856
Hom.:
2
Cov.:
82
AF XY:
0.0000853
AC XY:
62
AN XY:
726752
show subpopulations
African (AFR)
AF:
0.00367
AC:
123
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111976
Other (OTH)
AF:
0.000149
AC:
9
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000893
AC:
136
AN:
152376
Hom.:
0
Cov.:
35
AF XY:
0.000859
AC XY:
64
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00322
AC:
134
AN:
41600
American (AMR)
AF:
0.0000653
AC:
1
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000353
Hom.:
1
Bravo
AF:
0.00108
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000255
AC:
31

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypercholesterolemia (1)
-
-
1
Hypercholesterolemia, autosomal dominant, 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.060
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.47
T
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.92
D
M_CAP
Uncertain
0.085
D
MetaRNN
Benign
0.033
T
MetaSVM
Uncertain
0.68
D
MutationAssessor
Benign
1.6
L
PhyloP100
3.8
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-4.0
D
REVEL
Pathogenic
0.77
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.58
MVP
0.84
MPC
0.88
ClinPred
0.17
T
GERP RS
4.0
Varity_R
0.95
gMVP
0.53
Mutation Taster
=29/71
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72646508; hg19: chr1-55518422; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.